A significant inflection was demonstrated in call volume, with an additional 9.9 percent increase in semaglutide exposures per quarter after approval."When the GLP-1[RA] drugs are being sold to diabetic patients, that's a completely different story versus when the drug is used for weight management," coauthor David Han, Ph.D., also from UT San Antonio, said in a statement
Get personalized protocol planning at SeekPeptides - our AI advisor creates customized cagrilintide weight loss protocols based on your starting weight, goals, budget, and tolerance to side effects
Sold as non-clinical reference material
Each treatment is administered after a medical screening and under licensed medical oversight
The Role of GIP in New Weight Loss Medications Tirzepatide (Mounjaro) Tirzepatide is a GIP and GLP-1 receptor agonist approved for the treatment of type 2 diabetes and studied extensively for obesity